Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02878590 · ClinicalTrials.gov registry record · NA

Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)

A NA study of Obstructive Sleep Apnea, sponsored by InnoMed Healthscience.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02878590 is a NA study of Obstructive Sleep Apnea that has completed, run by InnoMed Healthscience. The registered enrollment target is 23 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02878590, a NA study of Obstructive Sleep Apnea, has completed, sponsored by InnoMed Healthscience.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Prospective, non-randomized, open label study

Conditions Studied

Interventions

  • DEVICE BONGO DEVICE

Study Locations (1)

California

  • California Center for Sleep Disorders - Alameda

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2016-09
Est. Completion 2017-11-30
Phase NA

Sponsor

InnoMed Healthscience

2 total trials

What the Registry Record Tells You About NCT02878590

The ClinicalTrials.gov registry entry for NCT02878590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower). The listed sponsor is InnoMed Healthscience, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which BONGO DEVICE is the first listed.

NCT02878590 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02878590 about?

NCT02878590 is a clinical study titled "Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)". Prospective, non-randomized, open label study

What is the current status of trial NCT02878590?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-09. Estimated completion is 2017-11-30.

What conditions does trial NCT02878590 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT02878590?

The interventions under investigation include: BONGO DEVICE (DEVICE).

Who is sponsoring clinical trial NCT02878590?

This trial is sponsored by InnoMed Healthscience, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02878590 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.